EZH2 and non-small cell lung carcinoma: On the other hand, KDM2B-mediated demethylation of H3K4me3, along with KDM6A-mediated demethylation of H3K27me3, has been found to promote EZH2 expression and the subsequent progression of non-small cell lung cancer [39].